Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55,351,475
-
Total 13F shares
-
51,125,783
-
Share change
-
+899,817
-
Total reported value
-
$186,608,210
-
Put/Call ratio
-
167%
-
Price per share
-
$3.65
-
Number of holders
-
67
-
Value change
-
+$3,636,101
-
Number of buys
-
33
-
Number of sells
-
23
Institutional Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q1 2024
As of 31 Mar 2024,
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,125,783 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, HarbourVest Partners LLC, STATE OF WISCONSIN INVESTMENT BOARD, BlackRock Inc., Artal Group S.A., VANGUARD GROUP INC, Blue Owl Capital Holdings LP, PLATINUM INVESTMENT MANAGEMENT LTD, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.